Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer
- 15 October 1994
- Vol. 74 (8) , 2276-2280
- https://doi.org/10.1002/1097-0142(19941015)74:8<2276::aid-cncr2820740811>3.0.co;2-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Urokinase-type plasminogen activator and malignancyFibrinolysis, 1993
- Molecular aspects of tumor cell invasion and metastasisCancer, 1993
- Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.Proceedings of the National Academy of Sciences, 1990
- Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancerFibrinolysis, 1990
- Urokinase plasminogen activator and prognosis in breast cancerThe Lancet, 1990
- Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.The Journal of cell biology, 1989
- Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells.Molecular and Cellular Biology, 1989
- Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary reportCancer, 1988
- Antibodies to plasminogen activator inhibit human tumor metastasisCell, 1983
- Endogenous Activation of Latent Collagenase by Rheumatoid Synovial CellsNew England Journal of Medicine, 1977